Was Maureen O'Connell’s ACTG share sale under a Rule 10b5-1 trading plan?

The filing indicates the Rule 10b5-1 checkbox is not marked , meaning this 10,000-share sale of ACTG common stock on 2026-08-19 was not affirmatively reported as made under a Rule 10b5-1 trading plan.

Acacia Research (ACTG) director sells 10,000 shares in $4.57–$4.63 trades

Q: What insider transaction did ACTG director Maureen O'Connell report?

Maureen O'Connell reported a sale of 10,000 ACTG common shares on 2026-08-19 in an open-market transaction at a weighted average price of $4.60 per share , with prices ranging from $4.57 to $4.63 .

Q: At what price were the ACTG shares sold in Maureen O'Connell’s Form 4 filing?

The reported weighted average sale price was $4.60 per ACTG share . According to the filing footnote, the 10,000 shares were sold in multiple transactions at prices ranging from $4.57 to $4.63 , inclusive.

Q: How many ACTG shares does Maureen O'Connell own after this transaction?

After the reported sale, Maureen O'Connell directly owns 287,655 shares of ACTG common stock. This figure represents her directly held position following the 10,000-share disposition on 2026-08-19.

Q: What type of transaction did the ACTG Form 4 report for Maureen O'Connell?

The Form 4 reports a Code S transaction, described as a sale in open market or private transaction , for 10,000 shares of ACTG common stock at a weighted average price of $4.60 on 2026-08-19.

Filing Impact

(Neutral)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

ACACIA RESEARCH CORP (ACTG) director Maureen O'Connell reported selling 10,000 shares of ACTG common stock on 2026-08-19 in an open-market transaction. The weighted average sale price was $4.60 per share, with individual trades between $4.57 and $4.63. Following this sale, she directly holds 287,655 shares of ACTG common stock.

Insider Trade Summary

Net Seller: 10,000 shares

Net Sell 1 txn

Insider OCONNELL MAUREEN

Role Director

Sold 10,000 shs ($46K)

Type	Security	Shares	Price	Value
Sale	ACTG Common Stock ^F1	10,000	$4.60	$46K

Holdings After Transaction: ACTG Common Stock — 287,655 shares (Direct)

Footnotes (1)

F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.57 to $4.63, inclusive. The Reporting Person undertakes to provide to Acacia Research Corporation ("Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form.

Key Figures

Shares sold: 10,000 shares Weighted average sale price: $4.60 per share Sale price range: $4.57–$4.63 per share +1 more

4 metrics

Shares sold 10,000 shares Non-derivative sale of ACTG common stock on 2026-08-19

Weighted average sale price $4.60 per share Weighted average for 10,000 shares sold on 2026-08-19

Sale price range $4.57–$4.63 per share Prices of multiple sale transactions included in the 10,000-share sale

Shares owned after transaction 287,655 shares Directly held ACTG common stock following the sale

Key Terms

weighted average price, open market or private transaction, non-derivative

3 terms

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open market or private transaction financial

"transaction code description: Sale in open market or private transaction"

non-derivative financial

"transaction_type: non-derivative"

FAQ

What insider transaction did ACTG director Maureen O'Connell report?

Maureen O'Connell reported a sale of 10,000 ACTG common shares on 2026-08-19 in an open-market transaction at a weighted average price of $4.60 per share, with prices ranging from $4.57 to $4.63.

At what price were the ACTG shares sold in Maureen O'Connell’s Form 4 filing?

The reported weighted average sale price was $4.60 per ACTG share. According to the filing footnote, the 10,000 shares were sold in multiple transactions at prices ranging from $4.57 to $4.63, inclusive.

How many ACTG shares does Maureen O'Connell own after this transaction?

After the reported sale, Maureen O'Connell directly owns 287,655 shares of ACTG common stock. This figure represents her directly held position following the 10,000-share disposition on 2026-08-19.

What type of transaction did the ACTG Form 4 report for Maureen O'Connell?

The Form 4 reports a Code S transaction, described as a sale in open market or private transaction, for 10,000 shares of ACTG common stock at a weighted average price of $4.60 on 2026-08-19.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/20/2026 - 07:23 PM Accepted by SEC EDGAR 08/20/2026 - 07:23 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

OCONNELL MAUREEN

(Last)

(First)

(Middle)

777 THIRD AVENUE

SUITE 2602

(Street)

NEW YORK

10017

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ACACIA RESEARCH CORP [ ACTG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
ACTG Common Stock	08/19/2026		S		10,000	D	$4.6⁽¹⁾	287,655	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.57 to $4.63, inclusive. The Reporting Person undertakes to provide to Acacia Research Corporation ("Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form.

Remarks:

	Jennifer Graff, Attorney-in-fact	08/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR